Biofrontera (BFRI) Gross Profit (2020 - 2025)
Biofrontera has reported Gross Profit over the past 6 years, most recently at $14.1 million for Q4 2025.
- For Q4 2025, Gross Profit rose 93.35% year-over-year to $14.1 million; the TTM value through Dec 2025 reached $30.7 million, up 64.26%, while the annual FY2025 figure was $30.7 million, 64.27% up from the prior year.
- Gross Profit for Q4 2025 was $14.1 million at Biofrontera, up from $4.9 million in the prior quarter.
- Over five years, Gross Profit peaked at $14.1 million in Q4 2025 and troughed at -$7.3 million in Q4 2022.
- A 5-year average of $5.4 million and a median of $4.5 million in 2021 define the central range for Gross Profit.
- Biggest five-year swings in Gross Profit: tumbled 181.57% in 2022 and later skyrocketed 263.03% in 2023.
- Year by year, Gross Profit stood at $9.0 million in 2021, then tumbled by 181.57% to -$7.3 million in 2022, then skyrocketed by 263.03% to $12.0 million in 2023, then plummeted by 39.02% to $7.3 million in 2024, then surged by 93.35% to $14.1 million in 2025.
- Business Quant data shows Gross Profit for BFRI at $14.1 million in Q4 2025, $4.9 million in Q3 2025, and $6.4 million in Q2 2025.